Meta-analysis examines whether aspirin is worth the risk for primary prevention

Despite clinically relevant reductions in nonfatal myocardial infarction (MI), the use of aspirin in patients without a history of cardiovascular disease (CVD) does not lead to reductions in either cardiovascular- or cancer-related death, according to a recently published meta-analysis.

The incidence of CVD in India is on the rise and may reach as high as 6.4 crore by 2015, according to estimates. Most of this increase in CVD is due to an increased incidence of coronary heart disease, including acute myocardial infarction, angina, heart failure, and inflammatory heart disease. As a result of these increasing event rates, death due to CVD is projected to...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Cardiology, Cardiovascular Disease, Pharmacology and tagged , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.